SY
So-Young International Inc.
There isn't enough reported data to score SY yet.
SY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Strong |
SY's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
SY PE Valuation
SY has no meaningful PE right now: it lost money over the past year.
SY Forward outlook
There aren't enough analyst estimates for SY to show an outlook.
SY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.28 | +$0.46 |
| Q1 2026 | -$0.29 | +$0.39 |
| Q4 2025 | -$0.27 | +$0.39 |
| Q3 2025 | -$0.84 | -2200% |
| Q2 2025 | -$0.74 | -1950% |
| Q1 2025 | -$0.68 | -6900% |
| Q4 2024 | -$0.66 | -3400% |
| Q3 2024 | $0.04 | 0% |
SY lost $0.28 per share over the past year, a smaller loss than the year before.
SY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $75.6M | +33% |
| Q1 2026 | $64.6M | +45% |
| Q4 2025 | $68.2M | +23% |
| Q3 2025 | $58M | +4% |
| Q2 2025 | $56.8M | -7% |
| Q1 2025 | $44.6M | -6.6% |
| Q4 2024 | $55.4M | -5.5% |
| Q3 2024 | $55.8M | -3.5% |
SY's revenue has grown year over year for four quarters in a row: $76M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.6% | +3.8 points |
| Q1 2026 | -13% | +1.2 points |
| Q4 2025 | -22% | +140 points |
| Q3 2025 | -19% | -20 points |
| Q2 2025 | -12% | -14 points |
| Q1 2025 | -15% | -3 points |
| Q4 2024 | -162% | -161 points |
| Q3 2024 | 1.3% | +1.8 points |
SY's operating margin was −8.6% last quarter, up 3.8 points from the same quarter a year ago.
SY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$45.3M | -$45.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
SY's free cash flow was −$45M over the past year, against $0 the year before.
SY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +187K shares |
| 1 year | -0.1% | -75.7K shares |
| 3 years | +0.6% | +796K shares |
| 5 years | -6.3% | -8.9M shares |
| Available history | -6.2% | -8.6M shares |
SY has 131M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
SY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -73.4x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -4.1x | Net Cash |
| Q1 2024 | -6.3x | Net Cash |
| Q4 2023 | -5.1x | Net Cash |
| Q3 2023 | -5.3x | Net Cash |
| Q2 2023 | -17.6x | Net Cash |
| Q1 2023 | -141.9x | Net Cash |
SY has more cash than debt.
SY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 12.9 | Oversold |
SY's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
SY PE vs Healthcare Sector
| Metric | SY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SY has no meaningful PE right now: it lost money over the past year.
SY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.29 | 15% below |
| 20 week MA | $2.22 | 13% below |
| 50 week MA | $2.50 | 22% below |
| 100 week MA | $2.35 | 17% below |
| 200 week MA | $1.88 | 3.2% above |
SY has fallen below most of its moving averages, though it's still 3.2% above its 200-week average.
SY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $11.4 | -4.4% |
| 2021 | $11.4 | $3.13 | -73% |
| 2022 | $3.13 | $1.39 | -56% |
| 2023 | $1.39 | $1.29 | -7.2% |
| 2024 | $1.29 | $0.82 | -36% |
| 2025 | $0.82 | $2.63 | +221% |
| 2026 YTD | $2.63 | $1.94 | -26% |
SY's yearly returns have swung widely, from +221% in 2025 to −73% in 2021. It's down 26% so far in 2026.